November 24th 2023, 2:00pm
A treatment combination that includes Velcade and Rituxan helps improve responses and the safety profile in marginal zone lymphoma, according to a phase 2 trial.
November 23rd 2023, 3:00pm
Datopotamab deruxtecan elicited encouraging responses in patients with heavily pretreated non–small cell lung cancer harboring actionable genomic alterations.
November 22nd 2023, 11:00pm
The Welireg-Cabometyx treatment combination demonstrated anti-tumor activity for some patients with clear cell renal carcinoma, according to a phase 2 trial.
November 7th 2023, 2:00pm
Findings from a phase 2 trial showed improvements in relapse-free survival with an mRNA vaccine plus Keytruda compared with Keytruda alone in patients with high-risk resected melanoma.
November 5th 2023, 10:00pm
Patients with extensive-stage small cell lung cancer responded well to the treatment of Trodelvy, according to preliminary results from a phase 2 trial.
October 30th 2023, 10:00pm
A phase 2 study evaluated meaningful activity from lifileucel for patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors.
October 30th 2023, 2:00pm
CURE® editors discuss data from the European Society of Medical Oncology Annual Congress, and how it could lead to new therapies being approved.
October 29th 2023, 4:00pm
Jemperli plus chemotherapy demonstrated improvement in overall survival compared with Keytruda and chemotherapy in patients with treatment-naïve, nonsquamous non–small cell lung cancer.
October 29th 2023, 1:00pm
Treatment with Tecentriq plus Zejula and chemotherapy did not offer better outcomes to patients with recurrent ovarian cancer, according to results from a phase 3 trial.
October 28th 2023, 7:00pm
A recent phase 2 study showed promising survival improvements with neoadjuvant Libtayo in patients with cutaneous squamous cell carcinoma after a year and a half follow up.
Younger Survivors Have a Lower Risk of Secondary Primary Breast Cancer
Finding the Small Wins as an Oncology Nurse
Grateful for My Sister’s Life, Especially During a Cancer Recurrence
How to Self-Advocate During Bladder Cancer Awareness Month